DELCF News and Press, Delic Holdings From 05/04/22

Ketamine Wellness Centers (KWC) Introduces NAD+ Infusion Therapy Canada NewsWire KWC Becomes Largest Ketamine Provider in the U.S. to Offer NAD+, Will be Available to Patients at Six Clinic Locations Beginning May 9 GILBERT, Ariz. , May 4, 2022 ...

DELIC HOLDINGS CORP ANNOUNCES LATE FILING OF ANNUAL FINANCIAL STATEMENTS, MD&A AND MANAGEMENT CEASE TRADE ORDER DELIC HOLDINGS CORP ANNOUNCES LATE FILING OF ANNUAL FINANCIAL STATEMENTS, MD&A AND MANAGEMENT CEASE TRADE ORDER Canada NewsWire VANCOUVER, BC ...

Delic Holdings Corp was founded four years ago, devoted to making psychedelic drug therapies available to patients with hard-to-treat mental and emotional conditions The company’s research arm has received authorization in Canada to work with substances such as psilocybin, MDMA ...

Psychedelics are increasingly being studied as therapies for various mental health conditions, including treatment-resistant depression. Last week, advocacy workers, doctors, researchers and farmers gathered in South Lake Union to discuss how psychedelics could be used in the treatment of ...

Delic is committed to bringing science-backed benefits to as many people as possible while also changing the narrative around psychedelics It seeks to achieve this through education, products and services, and research on psychedelics So far, LSD and psilocybin have proven to reduce ...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, will be presenting at this year’s Planet MicroCap Showcase; the event is scheduled for May 3–5, 2022. During the showcase, Delic Holdings cofounder and CEO Matt ...

Delic Corp to Discuss Business Expectations, Growth Opportunities at Planet MicroCap Showcase PR Newswire Matt Stang , Co-founder and CEO of Delic Corp, will showcase the Company's strategic plans for the remainder of the year at the Planet MicroCap Showcase on M...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform, through its subsidiary and the largest ketamine therapy provider in the United States, Ketamine Wellness Centers (“KWC”), recently announced the expansion of its treatment options to include...

Various studies have found that psychedelic treatments have the potential to treat mental health conditions such as anxiety and depression, among others. This, coupled with the ineffectiveness of current treatments, has made investing in psychedelics appear even more lucrative. However, ...

SRAX (NASDAQ: SRAX) , a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2022 Cannabis and Psychedelic Conference, a preeminent virtual investor event, on April ...